Pregled bibliografske jedinice broj: 160194
Expression of Toll-like receptors in human peripheral blood cells of patients with systemic lupus erythematosus
Expression of Toll-like receptors in human peripheral blood cells of patients with systemic lupus erythematosus // Annual Meeting of the Croatian Immunological Society, Opatija 2004
Opatija, Hrvatska, 2004. (poster, domaća recenzija, sažetak, znanstveni)
CROSBI ID: 160194 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Expression of Toll-like receptors in human peripheral blood cells of patients with systemic lupus erythematosus
Autori
Cepika, Alma-Martina ; Soldo-Jureša, Dragica ; Morović-Vergles, Jadranka ; Gagro, Alenka
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
Annual Meeting of the Croatian Immunological Society, Opatija 2004
/ - , 2004
Skup
Annual Meeting of the Croatian Immunological Society
Mjesto i datum
Opatija, Hrvatska, 08.10.2004. - 10.10.2004
Vrsta sudjelovanja
Poster
Vrsta recenzije
Domaća recenzija
Ključne riječi
systemic lupus erythematosus; Toll-like receptors
Sažetak
Systemic lupus erythematosus (SLE) is a chronic disease of autoimmune origin seen predominately in women between the ages of 20 and 40. The disease is life-long, and accompanied with damages of multiple organ systems such as kidneys, heart, joints, skin, lungs and central nervous system. Few recent studies indicate that the Toll-like receptors (TLRs) might have a role in pathogenesis of SLE. Our study involved so far five newly-discovered SLE patients, which underwent the same therapy protocol, and their healthy, age- and gender-matched controls. The effect of corticosteroids alone or in combination with chloroquine was observed at three time points: before therapy, after three weeks and three months of therapy. The expression of Toll-like receptors (TLR2, TLR4 and TLR9) on peripheral blood mononuclear cells was determined by three-color immunofluorescence analysis on a flow cytometer. Our preliminary results showed the difference of TLR protein expression level before and during the course of therapy.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti
POVEZANOST RADA
Projekti:
0021004
Ustanove:
Imunološki zavod d.d.
Profili:
Alma-Martina Cepika
(autor)
Dragica Soldo-Jureša
(autor)
Jadranka Morović-Vergles
(autor)
Alenka Gagro
(autor)